178 related articles for article (PubMed ID: 33445120)
1. Do competing causes of mortality contribute to overdiagnosis in lung cancer screening?
Durham DD; Croswell JM; Marcus PM
Lung Cancer; 2021 Mar; 153():21-24. PubMed ID: 33445120
[TBL] [Abstract][Full Text] [Related]
2. Overdiagnosis in low-dose computed tomography screening for lung cancer.
Patz EF; Pinsky P; Gatsonis C; Sicks JD; Kramer BS; Tammemägi MC; Chiles C; Black WC; Aberle DR;
JAMA Intern Med; 2014 Feb; 174(2):269-74. PubMed ID: 24322569
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer screening overdiagnosis: reports of overdiagnosis in screening for lung cancer are grossly exaggerated.
Mortani Barbosa EJ
Acad Radiol; 2015 Aug; 22(8):976-82. PubMed ID: 25772581
[TBL] [Abstract][Full Text] [Related]
4. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
[TBL] [Abstract][Full Text] [Related]
5. The impact of overdiagnosis on the selection of efficient lung cancer screening strategies.
Han SS; Ten Haaf K; Hazelton WD; Munshi VN; Jeon J; Erdogan SA; Johanson C; McMahon PM; Meza R; Kong CY; Feuer EJ; de Koning HJ; Plevritis SK
Int J Cancer; 2017 Jun; 140(11):2436-2443. PubMed ID: 28073150
[TBL] [Abstract][Full Text] [Related]
6. Indolent, Potentially Inconsequential Lung Cancers in the Pittsburgh Lung Screening Study.
Thalanayar PM; Altintas N; Weissfeld JL; Fuhrman CR; Wilson DO
Ann Am Thorac Soc; 2015 Aug; 12(8):1193-6. PubMed ID: 26107281
[TBL] [Abstract][Full Text] [Related]
7. Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates.
Blom EF; Ten Haaf K; de Koning HJ
Lung Cancer; 2020 Jan; 139():200-206. PubMed ID: 31816564
[TBL] [Abstract][Full Text] [Related]
8. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Specific Mortality, All-Cause Mortality, and Overdiagnosis in Lung Cancer Screening Trials: A Meta-Analysis.
Ebell MH; Bentivegna M; Hulme C
Ann Fam Med; 2020 Nov; 18(6):545-552. PubMed ID: 33168683
[TBL] [Abstract][Full Text] [Related]
10. Overdiagnosis in lung cancer screening: Estimates from the German Lung Cancer Screening Intervention Trial.
González Maldonado S; Motsch E; Trotter A; Kauczor HU; Heussel CP; Hermann S; Zeissig SR; Delorme S; Kaaks R
Int J Cancer; 2021 Mar; 148(5):1097-1105. PubMed ID: 32930386
[TBL] [Abstract][Full Text] [Related]
11. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
Young RP; Duan F; Chiles C; Hopkins RJ; Gamble GD; Greco EM; Gatsonis C; Aberle D
Am J Respir Crit Care Med; 2015 Nov; 192(9):1060-7. PubMed ID: 26199983
[TBL] [Abstract][Full Text] [Related]
12. Prognostic selection and long-term survival analysis to assess overdiagnosis risk in lung cancer screening randomized trials.
Paci E; Puliti D; Carozzi FM; Carrozzi L; Falaschi F; Pegna AL; Mascalchi M; Picozzi G; Pistelli F; Zappa M;
J Med Screen; 2021 Mar; 28(1):39-47. PubMed ID: 32437229
[TBL] [Abstract][Full Text] [Related]
13. Incidental lung cancers identified at coronial autopsy: implications for overdiagnosis of lung cancer by screening.
Manser RL; Dodd M; Byrnes G; Irving LB; Campbell DA
Respir Med; 2005 Apr; 99(4):501-7. PubMed ID: 15763458
[TBL] [Abstract][Full Text] [Related]
14. Overdiagnosis of lung cancer with low-dose computed tomography screening: meta-analysis of the randomised clinical trials.
Brodersen J; Voss T; Martiny F; Siersma V; Barratt A; Heleno B
Breathe (Sheff); 2020 Mar; 16(1):200013. PubMed ID: 32194774
[TBL] [Abstract][Full Text] [Related]
15. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study.
Veronesi G; Maisonneuve P; Bellomi M; Rampinelli C; Durli I; Bertolotti R; Spaggiari L
Ann Intern Med; 2012 Dec; 157(11):776-84. PubMed ID: 23208167
[TBL] [Abstract][Full Text] [Related]
16. The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials.
Li M; Zhang L; Charvat H; Callister ME; Sasieni P; Christodoulou E; Kaaks R; Johansson M; Carvalho AL; Vaccarella S; Robbins HA
Int J Cancer; 2022 Nov; 151(9):1491-1501. PubMed ID: 35809038
[TBL] [Abstract][Full Text] [Related]
17. Overdiagnosis in lung cancer screening.
Yankelevitz DF; Henschke CI
Transl Lung Cancer Res; 2021 Feb; 10(2):1136-1140. PubMed ID: 33718051
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers.
Hazelton WD; Goodman G; Rom WN; Tockman M; Thornquist M; Moolgavkar S; Weissfeld JL; Feng Z
Math Biosci; 2012 Nov; 240(1):20-34. PubMed ID: 22705252
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]